Suppr超能文献

失眠颗粒通过褪黑素和细胞因子生物标志物的相关变化改善轮班护士的睡眠、情绪和工作表现:一项随机、双盲、安慰剂对照的试点研究。

Shimian granules improve sleep, mood and performance of shift nurses in association changes in melatonin and cytokine biomarkers: a randomized, double-blind, placebo-controlled pilot study.

作者信息

Zhang Li, Zhang Ruihuan, Shen Yan, Qiao Shuzhen, Hui Zhenliang, Chen Jun

机构信息

Department of Pharmacy, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xi'an, China.

Graduate School, Shaanxi University of Chinese Medicine, Xianyang, China.

出版信息

Chronobiol Int. 2020 Apr;37(4):592-605. doi: 10.1080/07420528.2020.1730880. Epub 2020 Feb 21.

Abstract

Shift nurses are prone to sleep problems and impaired nighttime alertness, with risk for reduced health status plus decreased performance, handling errors, and workplace accidents. Attention to and improvements in the situation of shift nurses are urgent. Shimian granules (SMG), an improved formula of Jieyuanshen with liver and tranquilizing effects, for more than a decade has been used in China as a herbal treatment of sleep disorders in clinical practice. However, clinical data on SMG have rarely been reported. This double-blinded, randomized, placebo-controlled, pilot clinical trial (ChiCTR-IOR-17013031) aimed to explore whether Shimian granules (SMG) improves sleep and affective state in shift nurses and in association with changes in concentrations of salivary cytokines. Fifty-three rotating-shift female nurses with a Pittsburgh Sleep Quality Index (PSQI) score ≥8 were orally treated with 10.0 g SMG or placebo 2 times daily (30 min after breakfast and 30 min before bed) for 1 month. The Insomnia Severity Index (ISI), a psychomotor vigilance task, Hospital Anxiety and Depression Scale (HADS-A/HADS-D), and levels of four salivary cytokines were evaluated by single time-of-day sampling at baseline and after 1 month of treatment. Significantly lower ISI, HADS, HADS-A, and HADS-D scores, but higher 1/mean reaction time (1/mRT) score, were found in shift nurses treated with SMG than in those who received placebo, and these effects were associated with changes in salivary melatonin, TNF, IL-1β, and IL-6 levels. These latter findings suggest melatonin, TNF, and IL-6 levels may be suitable biomarkers of ISI score in shift nurses, whereas TNF level may be a suitable biomarker of 1/mRT score and IL-6 level a suitable biomarker of HADS score in response to SMG treatment. The results of this pilot study suggest SMG can effectively improve sleep, alertness, plus anxiety and depression symptoms in shift nurses in association with changes in salivary cytokine levels. The results of this study provide an experimental basis for the evaluation of traditional Chinese medicines for the treatment of insomnia and underlying mechanisms of their actions that require detailed future exploration.

摘要

轮班护士容易出现睡眠问题和夜间警觉性受损,存在健康状况下降、工作表现降低、操作失误及工作场所事故的风险。关注并改善轮班护士的状况迫在眉睫。失眠颗粒(SMG)是解郁安神方的改良配方,具有疏肝安神作用,十多年来在中国一直作为治疗睡眠障碍的草药用于临床实践。然而,关于失眠颗粒的临床数据鲜有报道。这项双盲、随机、安慰剂对照的先导性临床试验(ChiCTR-IOR-17013031)旨在探讨失眠颗粒(SMG)是否能改善轮班护士的睡眠和情感状态以及与唾液细胞因子浓度变化的关系。53名匹兹堡睡眠质量指数(PSQI)评分≥8的轮班女性护士,每天口服10.0 g失眠颗粒或安慰剂2次(早餐后30分钟和睡前30分钟),持续1个月。在基线和治疗1个月后,通过单日单次采样评估失眠严重程度指数(ISI)、精神运动警觉任务、医院焦虑抑郁量表(HADS-A/HADS-D)以及四种唾液细胞因子的水平。与接受安慰剂的轮班护士相比,接受失眠颗粒治疗的轮班护士的ISI、HADS、HADS-A和HADS-D评分显著更低,但1/平均反应时间(1/mRT)评分更高,且这些效应与唾液褪黑素、TNF、IL-1β和IL-6水平的变化有关。后一项研究结果表明,褪黑素、TNF和IL-6水平可能是轮班护士ISI评分的合适生物标志物,而TNF水平可能是1/mRT评分的合适生物标志物,IL-6水平是对失眠颗粒治疗反应的HADS评分的合适生物标志物。这项先导性研究的结果表明,失眠颗粒可有效改善轮班护士的睡眠、警觉性以及焦虑和抑郁症状,并与唾液细胞因子水平的变化有关。本研究结果为评估中药治疗失眠及其作用的潜在机制提供了实验依据,未来需要进行详细探索。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验